IMARC Group, a leading market research company, has recently releases report titled “Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” offers a comprehensive analysis of the industry, which comprises insights on the peripheral vascular devicesmarket report. The global market size reached US$ 10.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.8% during 2023-2028.
Peripheral vascular disease (PVD) represents a circulatory condition caused, owing to the narrowing, blockage, or spasms in the blood vessels placed outside the heart and brain. Some commonly used tools to treat PVD comprise angioplasty catheters, vena cava filters, stent-grafts, and embolic protection devices (EPD). Peripheral vascular appliances are safe, minimize the risk of infection and irritation, improve blood flow, supply oxygenated blood through arteries, etc. As a result, they find wide applications in hospitals and clinics across the globe.
Request foe a sample brochure: https://www.imarcgroup.com/peripheral-vascular-devices-market/requestsample
Peripheral Vascular Devices Market Trends and Drivers:
The increasing incidence of venous diseases or CVI (chronic venous insufficiency) across numerous countries is primarily augmenting the peripheral vascular devices market. Furthermore, the growing geriatric population that is more susceptible to several illnesses, such as peripheral artery disease (PAD) and blockages, on account of physical inactivity and unhealthy dietary habits, is also bolstering the market growth. Apart from this, the shifting preferences toward minimally invasive surgeries (MIS), owing to fewer complications, less postoperative pain, shortened hospital stay, and faster recovery times, are further catalyzing the global market. Moreover, the widespread adoption of atherectomy appliances, on account of the growing prevalence of atherosclerosis, obesity, and lifestyle-related disorders, is acting as another significant growth-inducing factor. Besides this, the expanding healthcare sector, the inflating disposable income levels of the masses, and extensive research and development (R&D) activities are expected to drive the peripheral vascular devices market in the coming years.
Who are the key players operating in the peripheral vascular devices industry?
- Abbott Laboratories
- B. Braun SE (B. Braun Holding GmbH & Co. KG)
- Becton
- Dickinson and Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cook Group Incorporated
- Cordis Corporation
- iVascular S.L.U.
- Koninklijke Philips N.V.
- Medtronic plc and Terumo Medical Corporation.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Device Type:
- Peripheral Vascular Stents
- Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
- Peripheral Transluminal Angioplasty (PTA) Guidewires
- Atherectomy Devices
- Embolic Protection Devices
- Inferior Vena Cava Filters
- Others
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Care Centers
- Specialty Clinics
- Others
Breakup By Regions:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
